Breaking down Biden's prostate cancer diagnosis — here's what to know about the disease
Biden diagnosed with aggressive form of prostate cancer that has spread to his bones
Former President Joe Biden has been diagnosed with metastatic prostate cancer at age 82. The former president's office said he has an "aggressive form" of the cancer, which has spread to his bones.
His cancer was categorized as having a Gleason score of 9, which places him in Grade Group 5, the most severe category.
Here's what to know about the disease, its symptoms and treatments:
Prostate cancer symptoms
Most men are diagnosed with prostate cancer before they start showing symptoms, as early warning signs of prostate cancer are rare, according to Johns Hopkins Medicine. The severity of symptoms can depend on the location of the cancerous cells and how advanced the disease has become.
Symptoms can include urinary issues, such as frequent urination, weak or interrupted flow, blood in urine and trouble either holding in or starting urination, according to Johns Hopkins, which says other symptoms can include difficulty getting and maintaining an erection, painful ejaculation and pain or stiffness in the lower back, hips or upper thighs.
Urinary symptoms, such as frequent urination or difficulty urinating, are quite common in older men and are usually due to benign conditions like having an enlarged prostate, CBS News medical contributor Dr. Celine Gounder says.
But in this case, Biden's office said his symptoms led to a prostate exam that resulted in the discovery of a small nodule. Further testing determined it was cancerous.
Some urologists were surprised that the 82-year-old underwent prostate cancer screening at all, according to Dr. Gounder, because routine screening in men over 75 is controversial. Many prostate cancers at that age are slow-growing, and overtreatment can do more harm than good, she said.
Prior to the diagnosis, Biden had received a clean bill of health during a February 2024 physical, in which he was declared "fit to serve" while still in office.
His situation underscores the importance of tailoring medical decisions to the individual, Gounder says. The former president had new symptoms and is functionally active, which justified a closer look.
Gleason score and what bone metastasis means
Gleason scores are a grading system for prostate cancer, according to the Cleveland Clinic. Pathologists grade each tissue sample on a 1 to 5 scale. The lower the grade, the more cancer cells look like normal cells.
Each area of prostate cancer may have a different grade, so pathologists pick the two areas that make up most of the cancer. They add the two areas' grades to come up with a Gleason score, according to the Cleveland Clinic.
Biden had a Gleason score of 9 (Grade Group 5), which is determined by the pathologist who looked at cells under a microscope.
A score of 9 is the second highest on the scale, which goes to 10. For scores 8, 9 and 10, the "cells look very different from healthy cells, which is called poorly differentiated or undifferentiated," the Cleveland Clinic said.
The categorization suggests a poor prognosis without intervention, Gounder said, but there are treatment options available that can help.
Moreover, Biden's prostate cancer diagnosis came with the presence of bone metastases, meaning the disease has spread. It places him within the high/very high-risk management group.
Is prostate cancer curable?
Prostate cancer is often curable if it's identified and treated early, and many medical advancements have been made in recent years that can help with more severe cases.
"The good news is that prostate cancer actually has a lot of effective treatments, and so patients even who are diagnosed with more aggressive, more advanced stage disease, can live many years and have good quality of life," said Dr. Tanya Dorff, an oncologist who treats prostate and other genitourinary cancers at City of Hope Comprehensive Cancer Center in Los Angeles.
In Biden's case — given his age and health — the goal isn't to cure the disease but to control it, to slow progression and preserve quality of life, Dr. Gounder says. Since the former president is reportedly in good functional health, more aggressive treatment is on the table. But these decisions always weigh the benefits against the potential risks and side effects, based on the individual's overall condition and priorities.
While Biden's diagnosis represents a more aggressive form of prostate cancer, his office said the cancer appears to be hormone-sensitive. This means the cancer should respond to testosterone-blocking treatment, since testosterone fuels prostate cancer growth, Gounder explained.
Based on what is known about his diagnosis, the primary treatment would be to block testosterone with a medication like Lupron, she said. This might be combined with other hormone therapies like Zytiga, or even chemotherapy, depending on the specific case.
Bone-targeted treatments are also part of the strategy when the cancer has spread to the skeleton, Gounder sadded.
Biden is among an estimated 313,780 new cases of prostate cancer will be diagnosed in the U.S. this year, according to the American Cancer Society's Cancer Facts & Figures. Approximately 35,770 of them (11%) will die from the disease this year, the organization said.
Kiki Intarasuwan
Kiki Intarasuwan is a news editor for CBS News & Stations.
contributed to this report.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
4 hours ago
- The Hill
Why tariffs are already driving some healthcare premiums higher
Related video above: How patients and doctors can reduce healthcare costs (NEXSTAR) – Despite the focus on the price of cars, iPhones and other consumer goods, the Trump administration's tariffs are starting to drive up prices in an entirely different industry – healthcare. On Monday, Matt McGough, with nonprofit health policy organization KFF, wrote that several individual insurance companies have already notified state regulators that they will be raising premiums to offset the potential impact of tariffs on pharmaceuticals. Trump hasn't yet targeted pharmaceuticals with tariffs, but has repeatedly brought it up, including on Monday aboard Air Force One. 'We're going to be doing pharmaceuticals very soon,' Trump said, according to Reuters. 'That's going to bring all the companies back, into America.' In a May filing, the Independent Health Benefits Corporation (IHBC) said it was submitting a premium rate change of 38.4% for 2026, 'primarily due to increased costs due to inflation and tariffs, and changes in risk adjustment.' An IHBC spokesperson told Axios that roughly 3% of that increase was to directly account for the impact of tariffs, specifically on drug prices. McGough notes that there are other insurers who either haven't specifically mentioned the potential effect of tariffs or who declined to include an offsetting increase in 2026 premium rates. 'A large proportion of medical goods currently comes from international sources, including pharmaceuticals, medical devices and personal protective equipment, as well as other low-margin, high-use essentials like syringes, needles and blood pressure cuffs,' Tina Freese Decker, board chair of the American Hospital Association, wrote in a May post. 'Tariffs on these items could impact patient care by jeopardizing the availability of vital medications and essential health care devices. They also could raise costs for hospitals and heighten shortages and supply chain disruptions.' Meantime, millions of Affordable Care Act (ACA) enrollees could see an over 75% average increase in premiums if Biden-era subsidies aren't extended by Congress before they expire at the end of the year, according to KFF estimates. How much tariffs are weighing on the calculations of insurers will become a bit more clear on Aug. 1, Axios notes, when proposed 2026 premium rates are posted.
New York Post
5 hours ago
- New York Post
5 foods that naturally stimulate the ‘Ozempic hormone' — without drugs
Want to shed pounds without getting poked? Your fork might be the fix. While GLP-1 drugs like Ozempic and Wegovy have taken the weight-loss world by storm, there are some everyday foods that offer similar benefits naturally — no needle required. 'No one food is a magic bullet for anything, but getting a balanced diet rich in nutrition-dense foods is a great way to manage your appetite and feelings of being full,' Dr. Amir Khan, a general practitioner, said in an Instagram video. Advertisement Khan broke down five foods to add to your diet if you're looking to naturally boost your levels of GLP-1, the hunger-controlling hormone that these trendy drugs are designed to mimic. An added bonus: These foods are also packed with nutrients that benefit your whole body, not just your waistline. But first: what is GLP-1? Advertisement GLP-1 is a hormone released by the small intestine after you eat, according to the Cleveland Clinic. It plays several key roles in how the body processes food, including triggering insulin production to turn meals into energy and lower blood sugar levels. 5 About 12% of US adults have tried a GLP-1 drug. millaf – Advertisement It also suppresses glucagon, a hormone that raises blood sugar, and slows stomach emptying, which helps you feel fuller for longer. GLP-1 drugs mimic this natural process by curbing appetite and reducing food intake, often leading to weight loss. But according to Khan, some kitchen staples can produce similar effects. #1 Eggs Packed with protein and monounsaturated fats, eggs have been shown to help boost GLP-1 secretion. Advertisement 'Egg whites in particular are thought to be beneficial to GLP-1 release,' Khan said. 5 Eggs may even help trigger the release of GLP-1 and other satiety hormones. Mara Zemgaliete – A 2016 study compared a bagel breakfast to one with three eggs. The egg meal led to lower blood sugar after eating, less hunger, and reduced food intake over the next 24 hours. #2 Certain nuts Almonds, pistachios, and walnuts may help boost GLP-1 thanks to their fiber, protein, and healthy fats. These nutrients work together to slow digestion, leading to a more steady rise in blood sugar and improving insulin sensitivity. #3 High-fiber grains Grains like oats, barley and whole wheat are packed with soluble fiber, which dissolves in water and forms a gel-like substance in your gut. 5 Soluble fiber, found in oats, barley, and rye, slows down the digestion process. baibaz – Advertisement This gel slows digestion and the release of glucose into your bloodstream, preventing sugar spikes and triggering GLP-1 release. #4 Olive oil 'Studies suggest unsaturated fats, like those in olive oil, stimulate GLP-1 release better than saturated fats found in butter,' Khan explained. Olive oil also slows carbohydrate digestion, helping prevent rapid blood sugar spikes. Advertisement Its polyphenols and vitamin E provide antioxidant and anti-inflammatory benefits that support hormone regulation — including GLP-1. A 2021 review found that a Mediterranean diet rich in olive oil led to higher post-meal GLP-1 levels, improved insulin sensitivity, and lower blood sugar compared to diets high in saturated fats. #5 Some vegetables Veggies like Brussels sprouts, broccoli and carrots are loaded with fiber, which helps regulate blood sugar. Advertisement Gut bacteria break down that fiber into short-chain fatty acids, which Khan says signal gut cells to release GLP-1 into the bloodstream. 5 Vegetables are high in fiber, vitamins and minerals, which can help regulate blood sugar and GLP-1 levels. Wolfilser – A 2022 study found that eating vegetables before carbs significantly improved glucose and GLP-1 levels in people with type 2 diabetes — especially an hour after eating. America's weight problem Advertisement About one in eight US adults have tried a GLP-1 drug, according to a 2024 KFF poll. Among them, nearly four in 10 say weight loss was the primary reason. Obesity is an epidemic in America, with more than two in five adults and nearly one in five kids and teens classified as obese, per the CDC. The health fallout is huge. Obesity is a risk factor for a wide range of chronic conditions, including heart disease, type 2 diabetes, osteoarthritis, sleep apnea, kidney disease and even several cancers. But it's not just physical. Obesity can take a toll on mental health, with research showing it increases the risk of developing low self-esteem, depression, eating disorders and chronic stress. On top of that, people with obesity often face bias at school and work, taking a serious toll on their quality of life.
The Hill
8 hours ago
- The Hill
Dr. Oz welcomes move by states to reduce migrant health coverage
Dr. Mehmet Oz, the celebrity doctor who oversees Medicaid and Medicare for the Trump administration, welcomes the move by a trio of blue states — California, Illinois and Minnesota — to freeze or reduce health care benefits for undocumented migrants. He told NewsNation's 'CUOMO' on Friday that some states broadened their public medical programs to include migrants because they could leverage federal dollars to pay for it, but Medicaid is supposed to be reserved for the most vulnerable Americans. 'If we extend it to illegal immigrants without keeping tabs of what those costs are — and especially if we have a system that encourages states to do legalized money laundering, to push more money towards able-bodied individuals — the dollar doesn't stretch that far. You end up bankrupting the whole system,' the former TV host said Friday. In California, Gov. Gavin Newsom (D) proposes suspending new health care enrollment for undocumented adults, although existing patients would continue to receive some coverage. Illinois Gov. JB Pritzker (D) would go further, ending his state's immigrant adult health program, which covers more than 30,000 people, on July 1. Minnesota is making undocumented adults ineligible for health care assistance by the end of the year. 'Taking care of a large population of undocumented folks has become a problem, and states have to manage that,' Oz said. The top health official's comments come after the administration moved to end Obamacare's coverage of immigrants who entered the U.S. illegally as children, according to a final rule announced Friday. The provision will undo a Biden-era rule that was estimated to allow 147,000 immigrants to enroll in coverage. A federal judge blocked the rule from being enforced in 19 states, and it is still being litigated in court.
